Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.16
$0.07927.33%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.35% | 11.39% | 710.04% | 55.35% | 55.35% |
| Total Depreciation and Amortization | 35.88% | -10.43% | 185.30% | 0.41% | 0.41% |
| Total Amortization of Deferred Charges | -- | -- | -32.64% | -- | -- |
| Total Other Non-Cash Items | -10.71% | -55.13% | -112.69% | 2,666.41% | 2,666.41% |
| Change in Net Operating Assets | 64.76% | 14.01% | 10.69% | -2,867.66% | -2,867.66% |
| Cash from Operations | 9.25% | 0.75% | 36.88% | -5.51% | -5.51% |
| Capital Expenditure | -375.12% | -91.67% | -126.22% | 63.76% | 63.76% |
| Sale of Property, Plant, and Equipment | -22.60% | -- | 16.81% | -40.68% | -40.68% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.92% | 54.91% | 143.03% | -213.65% | -213.65% |
| Cash from Investing | -14.45% | -124.54% | 91.52% | -493.34% | -493.34% |
| Total Debt Issued | 34.24% | 70.00% | -12.83% | -46.31% | -46.31% |
| Total Debt Repaid | -20.97% | 19.60% | 10.19% | 44.67% | 44.67% |
| Issuance of Common Stock | -11.76% | -- | -5.77% | -- | -- |
| Repurchase of Common Stock | -- | -36.81% | 10.23% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 15.34% | 16.95% | -9.89% | -9.89% |
| Other Financing Activities | -5.24% | -14.16% | -18.28% | 1.27% | 16.14% |
| Cash from Financing | 141.31% | 107.54% | 20.34% | -5.84% | -5.84% |
| Foreign Exchange rate Adjustments | -395.64% | -27.16% | -80.31% | 164.32% | 164.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 468.23% | 67.51% | 925.38% | -43.23% | -43.23% |